from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2076c/-

LFCtreatmentdescriptionclass of inhibitor

-0.316

Amikacinug/mL Amikacintranslation

-0.715

Cap5-10ug/mL Capreomycintranslation

-0.554

Rox10-50 ug/mL Roxithromycintranslation

-0.413

SM2-5 ug/mL Streptomycintranslation

-1.610

Tet5-10 ug/mL Tetracyclinetranslation

0.560

Rif0.2-5ug/mL Rifampicintranscription

0.013

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.061

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.227

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.116

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.993

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.498

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.060

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.177

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.589

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.570

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.248

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.140

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.260

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.041

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.854

KCN5-20 ug/mL Potassium cyaniderespiration

0.458

NaN30.2-2 mM Sodium aziderespiration

-0.023

Nigericin50 uM Nigericinrespiration

0.006

TRC10-150 ug/mL Triclosanrespiration

-0.333

TRZ10-25 ug/mL Thioridazinerespiration

3.299

Valinomycin0.5-10 uM Valinomycinrespiration

-0.591

ZnSO42 mM ZnSO4respiration

-0.152

menadione6-10 ug/mL Menadionerespiration

-0.720

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.116

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.064

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.478

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.474

NRP_1Non-replicating persistence stage 1dosRassociated

-0.056

Amp0.2mg/mL AmpicillincellWall

-0.308

Cephalexin20-100 ug/mL CephalexincellWall

-0.111

Cerulenin0.32-5 ug/mL CerulenincellWall

0.499

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.077

EMB10-20 ug/mL EthambutolcellWall

-0.859

Eta12-40 ug/mL EthionamidecellWall

-0.938

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.376

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.850

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.933

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.683

BZA0.12 mg/mL BenzamidearomaticAmides

0.805

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.324

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.877

H2O24 mM hydrogen peroxideDNAdamaging

-0.184

Levo10 ug/mL LevofloxacinDNAdamaging

0.463

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.881

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.369

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.764

UVUV-irradiationDNAdamaging

-0.043

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.351

Antimycin12.5-50 ug/mL Antimycin A?

-0.463

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.465

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.574

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.537

PA8240.2-2 ug/mL PA-824?

-0.256

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.207

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.632

Verapamil50 uM Verapamil?

0.018

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.918

methoxatin10-20 ug/mL Methoxatin?